3839

Chia Tai Enterprises International Limited

HK Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
9.500000
Fair value
3.330449
Next-week expectancy
Undecided 51.16%
Sharemaestro

3839 Chart Pack

Chia Tai Enterprises International Limited

Exchange
HKG
Latest week
10 Jul 2026
Close
9.500000
Fair value
3.330449
Next-week expectancy
Undecided 51.16%
Generated
17 Jul 2026 10:51
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, 3839 rose 31.03%, moving from 7.25 to 9.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is 37.79 and has improved across the 12-week window. Market Dynamics is 0.47 on the latest week. Next-week expectancy is undecided at 51.16% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
9.50
12-Week Change
31.03%
Trend Signal
Active
Next-Week Expectancy
Undecided 51.16%
Signal Weeks
10 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
37.79
Market Dynamics
0.47

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
9.50
12-Week Change
31.03%
Trend Signal
Active
Next-Week Expectancy
Undecided 51.16%
Signal Weeks
10 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
37.79
Market Dynamics
0.47

Over the latest 12 completed weeks ending 2026-07-10, 3839 rose 31.03%, moving from 7.25 to 9.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is 37.79 and has improved across the 12-week window. Market Dynamics is 0.47 on the latest week. Next-week expectancy is undecided at 51.16% based on similar historical setup states.

Industry Peers

Hong Kong equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
1889 Sanai Health Industry Group Company Limited HKG 10 Jul 2026 0.15 0.21 0.13 0.20 27.92%
8329 Shenzhen Neptunus Interlong Bio-technique Company Limited HKG 10 Jul 2026 0.10 0.13 0.10 0.12 20.79%
0911 Qianhai Health Holdings Limited HKG 10 Jul 2026 0.64 0.92 0.63 0.72 12.50%
6998 Edding Genor Group Holdings Limited HKG 10 Jul 2026 1.83 1.98 1.71 1.97 7.65%
0897 Wai Yuen Tong Medicine Holdings Limited HKG 10 Jul 2026 0.27 0.32 0.27 0.29 7.41%
8049 Jilin Province Huinan Changlong Bio-pharmacy Company Limited HKG 10 Jul 2026 2.32 2.50 2.30 2.46 6.03%
2552 Hua Medicine (Shanghai) Ltd. HKG 10 Jul 2026 2.57 2.72 2.43 2.67 3.89%
1312 Kontafarma China Holdings Limited HKG 10 Jul 2026 0.03 0.03 0.03 0.03 3.70%
2096 Simcere Pharmaceutical Group Limited HKG 10 Jul 2026 11.68 12.38 11.34 12.09 3.51%
1498 PuraPharm Corporation Limited HKG 10 Jul 2026 0.29 0.30 0.29 0.30 3.45%
1513 Livzon Pharmaceutical Group Inc. HKG 10 Jul 2026 24.88 26.84 24.88 25.70 3.30%
3737 Zhongzhi Pharmaceutical Holdings Limited HKG 10 Jul 2026 0.67 0.70 0.66 0.69 2.99%
0867 China Medical System Holdings Limited HKG 10 Jul 2026 11.57 12.43 11.42 11.90 2.85%
2633 Jacobson Pharma Corporation Limited HKG 10 Jul 2026 1.06 1.09 1.04 1.09 2.83%
0455 Tianda Pharmaceuticals Limited HKG 10 Jul 2026 0.09 0.10 0.09 0.09 2.22%
0719 Shandong Xinhua Pharmaceutical Company Limited HKG 10 Jul 2026 5.69 6.04 5.67 5.80 1.94%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.